SCHEMBL22067720

SCHEMBL22067720

CNc1cc(C)ccc1C(N)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.51
ALDH1A1 P00352 5/20 0.51
GAA P10253 3/20 0.51
GLA P06280 1/20 0.51
HPGD P15428 2/20 0.43
NNMT P40261 1/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
MAP2K2 P36507 1/20 0.41
MAP2K1 Q02750 1/20 0.41
PARP1 P09874 1/20 0.41
RAB9A P51151 4/20 0.41
NPC1 O15118 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
SYK P43405 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8686668 0.83 HPGD (0.50) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL9796560 0.82 HPGD (0.44) KDM4EALDH1A1GAAHPGDMEN1
SCHEMBL16421199 0.82 CLCN2 (0.53) ALDH1A1GAAHPGDMEN1KMT2A
SCHEMBL14601264 0.81 HPGD (0.43) ALDH1A1GAAHPGDMEN1KMT2A
SCHEMBL13223473 0.81 ALDH1A1 (0.51) KDM4EALDH1A1GAAGLANNMT
SCHEMBL8240078 0.81 PLAU (0.41) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL22067718 0.80 MKNK2 (0.55) KDM4EALDH1A1GAAHPGDMEN1
SCHEMBL22957967 0.79 KDM4E (0.59) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL20806357 0.79 ALDH1A1 (0.39) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL7169725 0.79 KDM4E (0.74) KDM4EALDH1A1GAAGLAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11712438-B2 Phenyl derivatives as PGE2 receptor modulators IDORSIA PHARMACEUTICALS LTD (CH) 2023-08-01 US disclosed
US-11712438-B2 Phenyl derivatives as PGE2 receptor modulators IDORSIA PHARMACEUTICALS LTD (CH) 2023-08-01 US disclosed
EP-3625222-B1 PHENYL DERIVATIVES AS PGE2 RECEPTOR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2021-07-21 EP disclosed
US-20200179383-A1 PHENYL DERIVATIVES AS PGE2 RECEPTOR MODULATORS ACTELION PHARMACEUTICALS LTD (CH) 2020-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11712438-B2 Phenyl derivatives as PGE2 receptor modulators PTGER1, PTGER4, PTGER2 KDM4E 842/4885ALDH1A1 575/4885GAA 4875/4885
US-20200179383-A1 PHENYL DERIVATIVES AS PGE2 RECEPTOR MODULATORS PTGER1, PTGER4, PTGER2 KDM4E 791/4885ALDH1A1 527/4885GAA 4864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.